Immunohistochemical prognostication of Merkel cell carcinoma: P63 expression but not polyomavirus status correlates with outcome

Journal of Cutaneous Pathology

Volumn 39, Issue 10, 2012, Pages 911-917

  Hall, Brian J ^a   Pincus, Laura B ^b   Yu, Siegrid S ^c   Oh, Dennis H ^c   Wilson, Andrew R ^d   McCalmont, Timothy H ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

cancer; cutaneous neoplasm; immunohistochemistry; non melanoma skin cancer; p63

Indexed keywords

CKAP4 PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR MARKER;

AGED; ARTICLE; BIOSYNTHESIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; MERKEL CELL TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; POLYOMA VIRUS; POLYOMAVIRUS INFECTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SKIN TUMOR; VIROLOGY; VIRUS INFECTION;

AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR VIRUS INFECTIONS;

EID: 84866071876     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2012.01964.x     Document Type: Article

References (38)

1. Becker JC,. Merkel cell carcinoma. Ann Oncol 2010; 21 (Suppl. 7): vii81.
2. Dancey AL, Rayatt SS, Soon C, Ilchshyn A, Brown I, Srivastava S,. Merkel cell carcinoma: a report of 34 cases and literature review. J Plast Reconstr Aesthet Surg 2006; 59: 1294 [Epub 6 June 2006; Review].
3. Hodgson NC,. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005; 89: 1.
4. Feng H, Shuda M, Chang Y, Moore PS,. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096 [Epub 17 January 2008].
5. Shuda M, Feng H, Kwun HJ, et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA 2008; 105: 16272 [Epub 23 September 2008].
6. Shuda M, Arora R, Kwun HJ, et al. Human Merkel cell polyomavirus infection I. MCPV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 2009; 125: 1243.
7. Andres C, Belloni B, Puchta U, Sander CA, Flaig MJ,. Prevalence of MCPyV in Merkel cell carcinoma and non-MCC tumors. J Cutan Pathol 2010; 37: 28.
8. Duncavage EJ, Zehnbauer BA, Pfeifer JD,. Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma. Mod Pathol 2009; 22: 516 [Epub 27 February 2009].
9. Kuwamoto S, Higaki H, Kanai K, et al. Association of Merkel cell polyomavirus infection with morphologic differences in Merkel cell carcinoma. Hum Pathol 2011; 42: 632.
10. Tan BH, Busam KJ, Pulitzer MP,. Combined intraepidermal neuroendocrine (Merkel cell) and squamous cell carcinoma in situ with CM2B4 negativity and p53 overexpression. J Cutan Pathol 2012; 39: 626.
11. Paik JY, Hall G, Clarkson A, et al. Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population. Hum Pathol 2011 [Epub ahead of print].
12. Busam KJ, Jungbluth AA, Rekthman N, et al. Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol 2009; 33: 1378.
13. Sihto H, Kukko H, Koljonen V, Sankila R, Böhling T, Joensuu H,. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 2009; 101: 938 [Epub 17 June 2009].
14. Schrama D, Peitsch WK, Zapatka M, et al. Merkel cell polyomavirus status is not associated with clinical course of merkel cell carcinoma. J Invest Dermatol 2011; 131: 1631.
15. Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW,. Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome. Int J Cancer 2010; 127: 1493.
16. Paulson KG, Carter JJ, Johnson LG, et al. Antibodies to merkel cell polyomavirus Tantigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res 2010; 70: 8388 [Epub 19 October 2010].
17. Vanbokhoven H, Melino G, Candi E, Declercq W,. p63, a story of mice and men. J Invest Dermatol 2011; 131: 1196 [Epub 7 April 2011; Review].
18. Truong AB, Kretz M, Ridky TW, Kimmel R, Khavari PA,. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 2006; 20: 3185.
19. Asioli S, Righi A, de Biase D, et al. Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas. Mod Pathol 2011.
20. Asioli S, Righi A, Volante M, Eusebi V, Bussolati G,. p63 expression as a new prognostic marker in Merkel cell carcinoma. Cancer 2007; 110: 640.
21. Agoff SN, Lamps LW, Philip AT, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 2000; 13: 238.
22. Flores ER, Sengupta S, Miller JB, et al. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 2005; 7: 363.
23. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2: 305.
24. Houben R, Schrama D, Becker JC,. Molecular pathogenesis of Merkel cell carcinoma. Exp Dermatol 2009; 18: 193 (Review).
25. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG,. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005; 23: 2300.
26. Eng TY, Boersma MG, Fuller CD, Cavanaugh SX, Valenzuela F, Herman TS,. Treatment of merkel cell carcinoma. Am J Clin Oncol 2004; 27: 510.
27. Güler-Nizam E, Leiter U, Metzler G, Breuninger H, Garbe C, Eigentler TK,. Clinical course and prognostic factors of Merkel cell carcinoma of the skin. Br J Dermatol 2009; 161: 90 [Epub 29 April 2009].
28. Koljonen V, Böhling T, Granhroth G, Tukiainen E,. Merkel cell carcinoma: a clinicopathological study of 34 patients. Eur J Surg Oncol 2003.
29. Tai PT, Yu E, Tonita J, Gilchrist J,. Merkel cell carcinoma of the skin. J Cutan Med Surg 2000; 4: 186 (Review).
30. Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010; 63: 751 [Epub 19 June 2010].
31. Beer TW, Ng LB, Murray K,. Mast cells have prognostic value in Merkel cell carcinoma. Am J Dermatopathol 2008; 30: 27.
32. Mott RT, Smoller BR, Morgan MB,. Merkel cell carcinoma: a clinicopathologic study with prognostic implications. J Cutan Pathol 2004; 31: 217.
33. Andea AA, Coit DG, Amin B, Busam KJ,. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008; 113: 2549.
34. Skelton HG, Smith KJ, Hitchcock CL, McCarthy WF, Lupton GP, Graham JH,. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 1997; 37 (5 Pt 1): 734.
35. Koljonen V, Tukiainen E, Haglund C, Böhling T,. Proliferative activity detected by Ki67 correlates with poor outcome in Merkel cell carcinoma. Histopathology 2006; 49: 551.
36. Paulson KG, Iyer JG, Teeter AR, et al. Transcriptome-wide studies of Merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol 2011 [Epub ahead of print].
37. Goldberg SR, Neifeld JP, Frable WJ,. Prognostic value of tumor thickness in patients with Merkel cell carcinoma. J Surg Oncol 2007; 95: 618.
38. Sandel HD 4th, Day T, Richardson MS, Scarlett M, Gutman KA,. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival? Laryngoscope 2006; 116: 791.